Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

HHV-6, HHV-7 Viral Loads & HERV K18 Expression in CFS

Discussion in 'Latest ME/CFS Research' started by Gemini, Feb 21, 2013.

  1. The way I have been looking at it, brain fog is a component of chronic "subclinical" encephalitis (or more appropriately perhaps encephalopathy). When it all boils down it is the lethargy, the mental fatigue and the cognitive dsyfunction which are the main components of disability and reduced QOL with CFS. So the research on encephalitis and HHV-6 (much of which can be related to reactivations rather than acute encephalitis) is quite critical to the whole topic of CFS.
     
  2. Sasha

    Sasha Fine, thank you

    Messages:
    14,329
    Likes:
    29,415
    UK
    Interesting argument. Would an infectious diseases specialist recognise those symptoms (all of which I have) as subclinical encephalitis/opathy?
     
    merylg and ukxmrv like this.
  3. Hip

    Hip Senior Member

    Messages:
    6,420
    Likes:
    7,748
    Dr Jon Wilcox, what is your view on enteroviruses such as coxsackievirus B causing a low-level infection of the brain leading to ME/CFS? CVB has been shown capable of infecting the astrocyte cells of the mouse brain (ref: 1), and infecting neuronal progenitor cells (ref: 1).

    A lot of people look to HHV-6 as the main culprit in ME/CFS. However, many people develop ME/CFS in their 20s and 30s after catching a respiratory virus, and this virus is unlikely to be HHV-6, because most humans will pick up HHV-6 much earlier in life, typically before the age of 3. Thus the virus that triggers ME/CFS would need to be a virus that is not acquired early in life, but one that is typically acquired in the 20s and 30s. The six serotypes of coxsackievirus B are good candidates for such a virus acquired later in life.

    Of course, with coxsackievirus B being immunosuppressive, this could lead to the reactivation of HHV-6, EBV, CMV, etc.
     
    physicsstudent13 and merylg like this.
  4. physicsstudent13

    physicsstudent13 Senior Member

    Messages:
    576
    Likes:
    33
    US
    what would be some of the most effective treatments for HHV-6, is famvir or valcyte which inhibit proper DNA polymerization possibly going to eradicate or put the virus into remission?
    I don't know how effective this less expensive OTC supplement would be
    http://www.ncbi.nlm.nih.gov/pubmed/24611562
    it's interesting how viruses are being used to treat brain cancer now
     

See more popular forum discussions.

Share This Page